Suppr超能文献

小儿肌张力障碍的最新进展:病因、流行病学及管理

Update on pediatric dystonias: etiology, epidemiology, and management.

作者信息

Fernández-Alvarez Emilio, Nardocci Nardo

机构信息

Neuropediatric Department, Hospital San Juan de Dios, Barcelona, Spain,

Child Neurology Department, Fondazione IRCCS Istituto Neurologico "C. Besta", Milano, Italy.

出版信息

Degener Neurol Neuromuscul Dis. 2012 Apr 11;2:29-41. doi: 10.2147/DNND.S16082. eCollection 2012.

Abstract

UNLABELLED

Dystonia is a movement disorder characterized by sustained muscle contractions producing twisting, repetitive, and patterned movements or abnormal postures. Dystonia is among the most commonly observed movement disorders in clinical practice both in adults and children. It is classified on the basis of etiology, age at onset of symptoms, and distribution of affected body regions.

ETIOLOGY

The etiology of pediatric dystonia is quite heterogeneous. There are many different genetic syndromes and several causes of symptomatic syndromes. Dystonia can be secondary to virtually any pathological process that affects the motor system, and particularly the basal ganglia.

CLASSIFICATION

The etiological classification distinguishes primary dystonia with no identifiable exogenous cause or evidence of neurodegeneration and secondary syndromes.

TREATMENT

Treatment for most forms of dystonia is symptomatic and includes drugs (systemic or focal treatments, such as botulinum toxin) and surgical procedures. There are several medications including anticholinergic, dopamine-blocking and depleting agents, baclofen, and benzodiazepines. In patients with dopamine synthesis defects L-dopa treatment may be very useful. Botulinum toxin treatment may be helpful in controlling the most disabling symptoms of segmental or focal dystonia. Long-term electrical stimulation of the globus pallidum internum appears to be especially successful in children suffering from generalized dystonia.

摘要

未标注

肌张力障碍是一种运动障碍,其特征为肌肉持续收缩,产生扭曲、重复且有模式的运动或异常姿势。肌张力障碍是临床实践中成人和儿童最常见的运动障碍之一。它根据病因、症状出现的年龄以及受影响身体部位的分布进行分类。

病因

小儿肌张力障碍的病因非常多样。存在许多不同的遗传综合征以及多种症状性综合征的病因。肌张力障碍实际上可继发于任何影响运动系统,尤其是基底神经节的病理过程。

分类

病因分类区分无明确外源性病因或神经退行性变证据的原发性肌张力障碍和继发性综合征。

治疗

大多数形式的肌张力障碍治疗为对症治疗,包括药物(全身或局部治疗,如肉毒杆菌毒素)和手术程序。有多种药物,包括抗胆碱能药、多巴胺阻断和耗竭剂、巴氯芬和苯二氮䓬类药物。对于多巴胺合成缺陷的患者,左旋多巴治疗可能非常有用。肉毒杆菌毒素治疗可能有助于控制节段性或局灶性肌张力障碍最致残的症状。对苍白球内侧部进行长期电刺激似乎对患有全身性肌张力障碍的儿童特别有效。

相似文献

1
Update on pediatric dystonias: etiology, epidemiology, and management.小儿肌张力障碍的最新进展:病因、流行病学及管理
Degener Neurol Neuromuscul Dis. 2012 Apr 11;2:29-41. doi: 10.2147/DNND.S16082. eCollection 2012.
2
Chapter 33: the history of movement disorders.第33章:运动障碍病史。
Handb Clin Neurol. 2010;95:501-46. doi: 10.1016/S0072-9752(08)02133-7.
3
Nonprimary dystonias.非原发性肌张力障碍
Handb Clin Neurol. 2011;100:513-38. doi: 10.1016/B978-0-444-52014-2.00038-0.
5
Clinical phenomenology of dystonia.肌张力障碍的临床现象学。
Int Rev Neurobiol. 2011;98:509-24. doi: 10.1016/B978-0-12-381328-2.00018-3.
6
Adult-onset dystonia.成人起病性肌张力障碍
Handb Clin Neurol. 2011;100:481-511. doi: 10.1016/B978-0-444-52014-2.00037-9.
7
The Dystonias.《肌张力障碍》
Continuum (Minneap Minn). 2022 Oct 1;28(5):1435-1475. doi: 10.1212/CON.0000000000001159.
8
Deep Brain Stimulation for Dystonia.用于治疗肌张力障碍的深部脑刺激术
Curr Treat Options Neurol. 2005 May;7(3):237-243. doi: 10.1007/s11940-005-0017-z.
9
Task-specific dystonias: a review.特定任务性肌张力障碍:综述
Ann N Y Acad Sci. 2008 Oct;1142:179-99. doi: 10.1196/annals.1444.012.
10
Classification and genetics of dystonia.肌张力障碍的分类与遗传学
Lancet Neurol. 2002 Sep;1(5):316-25. doi: 10.1016/s1474-4422(02)00137-0.

引用本文的文献

本文引用的文献

6
Advances in the genetics of primary torsion dystonia.
F1000 Biol Rep. 2010 Jun 16;2:41. doi: 10.3410/B2-41.
8
Therapeutic challenges in dystonia.肌张力障碍的治疗挑战。
Neurol Clin. 2010 Nov;28(4):927-40. doi: 10.1016/j.ncl.2010.03.020. Epub 2010 Jul 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验